Over 100 Total Lots Up For Auction at One Location - UT 10/25

Joseph J. Cappello

Are You Dense, Inc. and Are You Dense Advocacy, Inc. announce executive director of both organizations
February 19, 2019
Women's Health
Joseph J. Cappello
Woodbury, Conn., Feb. 18, 20019 — The boards of the two nonprofits founded by the late Nancy M. Cappello, PhD, has announced today Joseph J. Cappello as their new executive director. For over a decade, Mr. Cappello has worked tirelessly, side-by-side as co-founder of the organizations with his wife, Dr. Cappello, earning him a unique perspective of the critical issue on adjunct screening for women with dense breast tissue.

"Duty compels me to carry on my wife's mission," declares Mr. Cappello. "Women have the right to know their breast density status, to have their complete breast health information. This vital piece of information was denied to Nancy when she was originally diagnosed with late stage 3c breast cancer in 2004. As a result of her hard work, 36 states currently mandate physicians to tell their patients their breast density status.

"Now, we are focusing our energies on getting legislation passed in the remaining 14 states" adds Mr. Cappello.

Science for decades has demonstrated that dense breast tissue is associated with a higher-than-average risk of breast cancer and that dense breast tissue can mask cancers on mammograms, making them impossible to detect. Adjunct screening to mammography, such as ultrasound and MRI, significantly increase detection of early cancers in dense breasts.

Dr. Cappello launched the legislative action of her organizations after being diagnosed with advanced-stage breast cancer in 2004 despite decades of normal mammography results. None of Dr. Cappello's physicians told her that she had dense breast tissue, which had hidden the growing cancer in her breast, and none advised her to get adjunct screening. Her home state of Connecticut passed the first bill in 2009.

Dr. Cappello passed away this past November due to complications from Myelodysplastic syndrome (MDS), a rare form of bone marrow cancer, and in some instances, may be associated with previous radiation and chemotherapy cancer treatments.

"I am empowered and honored to further the Are You Dense? mission," continues Mr. Cappello. "That being to reduce missed, delayed and advanced stage breast cancer by increasing access to early detection for women with dense breasts leading to reduced harms from aggressive treatments and better survival outcomes."

You Must Be Logged In To Post A Comment

 

advertisement

Women's Health Homepage

Study shows Lunit AI can predict breast cancer years before it is clinically detectable
Could lead to tailored preventive measures and earlier diagnoses
Siemens Healthineers nabs FDA premarket approval for 3D imaging for mammo system
Mammomat B.brilliant is the company's first redesigned mammo platform in over a decade
Using AI for personalized breast cancer risk assessment: An important tool for early detection
Insights from Lester Litchfield, head of data science for Volpara Health, a Lunit company
Ten-year study reveals that tomosynthesis can better detect cancer than 2D digital mammography
It increases the cancer detection rate and reduces the rate of advanced cancers
Koning touts several new installs for Vera Breast CT
Reports expanded adoption in Jamaica, California, and Texas, among other locations
The financial burden of recalls and retakes in breast cancer screening
Insights from Erik Anderson, president of breast & skeletal health solutions at Hologic
Study finds false-positive mammograms reduce likelihood of future screenings
But those with false-positive findings are at increased risk of breast cancer in future
How many billions of dollars are spent on cancer screening in the US annually?
Researchers have crunched the numbers based on data from 2021
Supplemental screening may be out of reach for patients with dense breast tissue
Researchers emphasize potential for contrast-enhanced mammo to improve outcomes
Jefferson Hospital finishes $4.6 million breast imaging center renovation
Enlarged by nearly 2,000 square feet, doubling its monthly diagnostic breast exam capacity